Moreau, Philippe
van de Donk, Niels W. C. J.
Delforge, Michel
Einsele, Hermann
De Stefano, Valerio
Perrot, Aurore
Besemer, Britta
Pawlyn, Charlotte
Karlin, Lionel
Manier, Salomon
Leleu, Xavier
Weisel, Katja
Ghilotti, Francesca
Diels, Joris
Elsada, Ahmed
Morano, Raul
Strulev, Vadim
Pei, Lixia
Kobos, Rachel
Smit, Jennifer
Slavcev, Mary
Mateos, Maria-Victoria
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma
https://doi.org/10.1007/s12325-023-02480-7
Funding for this research was provided by:
MajesTEC-1 was funded by Janssen Research & Development, LLC
LocoMMotion was funded by Janssen Research & Development, LLC and Legend Biotech, Inc.
Universidad de Salamanca
Article History
Received: 6 December 2022
Accepted: 21 February 2023
First Online: 24 March 2023